| Title : Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care - Behrens_2018_Int.Psychogeriatr__1 |
| Author(s) : Behrens S , Rattinger GB , Schwartz S , Matyi J , Sanders C , DeBerard MS , Lyketsos CG , Tschanz JT |
| Ref : Int Psychogeriatr , :1 , 2018 |
| Abstract : Behrens_2018_Int.Psychogeriatr__1 |
| ESTHER : Behrens_2018_Int.Psychogeriatr__1 |
| PubMedSearch : Behrens_2018_Int.Psychogeriatr__1 |
| PubMedID: 29559029 |
Behrens S, Rattinger GB, Schwartz S, Matyi J, Sanders C, DeBerard MS, Lyketsos CG, Tschanz JT (2018)
Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care
Int Psychogeriatr
:1
Behrens S, Rattinger GB, Schwartz S, Matyi J, Sanders C, DeBerard MS, Lyketsos CG, Tschanz JT (2018)
Int Psychogeriatr
:1